This is SCIENCE FRIDAY. I'm Ira Flatow. Over 115,000 Americans are currently waiting for an organ transplant, and most of them are in need of a kidney. Now, what if we could just create a kidney for them in the laboratory? One of my next guests has experimented with printing out organs using an inkjet printer, but instead of ink, he uses cells.
Mathematician Ian Stewart joins the Science Friday Book Club meeting to discuss Edwin Abbott's classic Flatland. The book, published in 1884 under the pseudonym "A. Square," tells the story of a two-dimensional world where women are straight lines and men are polygons.
Originally published on Fri September 21, 2012 12:18 pm
By April Fulton
Credit Maggie Starbard / NPR
Salt — it's the ultimate condiment. It's the only rock we eat, and it makes our food taste better. There are dozens of varieties, from hand-harvested Himalayan pink to plain-old kosher, to various herb-infused blends. But, as we report a lot around here, when we eat too much, it can be bad for our health.
A man-made bat cave in Tennessee is looking for tenants. An hour northwest of Nashville, the artificial cave is built to give thousands of bats a haven from a devastating infection called white-nose syndrome.
Millions of bats in the Northeast have died from the infection since it first showed up a few years ago. The culprit is an invasive fungus that grows in caves. When bats hibernate inside, they wake up with faces covered in white fuzz and often wind up starving or freezing to death.
There's some big news out today about one of the most sensitive issues in medicine: Who's next in line for a transplant?
The United Network for Organ Sharing, or UNOS, a nonprofit in charge of distributing organs, wants to revamp the system for distributing the most sought-after organ — kidneys — for the first time in 25 years.
The headlines on the press releases that started showing up yesterday, here at The Salt certainly got our attention. Just one sample: "BREAKING NEWS: New Study Links Genetically Engineered Food to Tumors."
An experimental drug that helps people who have Fragile X syndrome is raising hopes of a treatment for autism.
The drug, called arbaclofen, made people with Fragile X less likely to avoid social interactions, according to a study in Science Translational Medicine. Researchers suspect it might do the same for people with autism.